ClinicalTrials.gov
public full text
Public Domain
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
Our hypothesis is that prophylactic administration of 5 days of Octreotide following EMR or ampullectomy in patients with duodenal and ampullary adenomas greater than or equal to 10mm.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Upper Rectal Artery Embolization in the Treatment of Hemorrhoidal Disease#868048
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer#1231529
- French Register of Duodenal Adenomas Characterization and Evaluation of Endoscopic Mucosectomy#1197673
- Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection#804670
- Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas#917167
Record · ID 1294781
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive